Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-8 of 8
Keywords: Amyloid-β
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Seon Young Ryu, Yun Jeong Hong, SeongHee Ho, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Seong Hye Choi, Dong Won Yang
Dement Geriatr Cogn Disord (2022) 51 (2): 159–167.
Published Online: 05 April 2022
... and the Alzheimer’s Association criteria for preclinical AD proposed that subtle cognitive changes appear along with AD biomarkers in the late stage of preclinical AD. The objective of this study was to explore whether subtle cognitive impairment (SCI) in individuals with SCD is associated with brain amyloid-β (Aβ...
Journal Articles
Dement Geriatr Cogn Disord (2015) 40 (1-2): 54–62.
Published Online: 13 May 2015
... the pathology and disease progression are essential for diagnosis and are important when developing new therapies. Today, the core protein biomarkers amyloid-β 42 , total tau and phosphorylated tau in the cerebrospinal fluid (CSF) are used to diagnose Alzheimer's disease (AD), because these biomarkers have...
Journal Articles
Maryam Noroozian, Parisa Azadfar, Leila Akbari, Arghavan Sadeghi, Massoud Houshmand, Nasim Vousooghi, Mohammad Reza Zarrindast, Alireza Minagar
Dement Geriatr Cogn Disord (2014) 38 (5-6): 330–336.
Published Online: 14 August 2014
..., instructions or products referred to in the content or advertisements. Early-onset Alzheimer’s disease APP gene Amyloid-β Mutation Val717Ile Iran Alzheimer's disease (AD) is a progressive neurodegenerative disease, which affected more than 35 million individuals worldwide in 2010...
Journal Articles
Magdalena Nutu, Henrik Zetterberg, Elisabet Londos, Lennart Minthon, Katarina Nägga, Kaj Blennow, Oskar Hansson, Annika Öhrfelt
Dement Geriatr Cogn Disord (2013) 36 (1-2): 99–110.
Published Online: 09 July 2013
...) and Parkinson's disease with dementia (PDD). This study aimed to evaluate whether the cerebrospinal fluid (CSF) amyloid-β (Aβ) 1-42 /Aβ 1-40 ratio, measured by a novel method, could improve the differential diagnosis of AD, DLB and PDD. Method: CSF levels of Aβ 1-40 and Aβ 1-42 in patients with PDD, DLB, AD...
Journal Articles
Elin S. Blom, Vilmantas Giedraitis, Henrik Zetterberg, Hiroaki Fukumoto, Kaj Blennow, Bradley T. Hyman, Michael C. Irizarry, Lars-Olof Wahlund, Lars Lannfelt, Martin Ingelsson
Dement Geriatr Cogn Disord (2009) 27 (5): 458–464.
Published Online: 07 May 2009
... to in the content or advertisements. Alzheimer’s disease Mild cognitive impairment Biomarkers Cerebrospinal fluid Tau Phospho-tau Amyloid-β Apolipoprotein E Disease progression Original Research Article Dement Geriatr Cogn Disord 2009;27:458 464 DOI: 10.1159/000216841 Accepted: January 30, 2009...
Journal Articles
Hillevi Englund, Göran Annerén, Jan Gustafsson, Ulrika Wester, Jens Wiltfang, Lars Lannfelt, Kaj Blennow, Kina Höglund
Dement Geriatr Cogn Disord (2007) 24 (5): 369–374.
Published Online: 03 October 2007
... trying to elucidate early events in AD pathogenesis. Aim: To investigate how levels of different amyloid-β (Aβ) peptides, as well as tau and phosphorylated tau, in cerebrospinal fluid (CSF) from children with DS change over time. The first CSF sample was taken at 8 months and the following two samples...
Journal Articles
Dement Geriatr Cogn Disord (2005) 19 (5-6): 357–360.
Published Online: 29 April 2005
..., instructions or products referred to in the content or advertisements. Butyrylcholinesterase K genotype Alzheimer’s disease Dementia with Lewy bodies Phosphorylated tau Amyloid-β Temporal cortex Original Research Article Dement Geriatr Cogn Disord 2005;19:357 360 DOI: 10.1159/000084705 Accepted...
Journal Articles
Franco Giubilei, Giovanni Antonini, Chiara Montesperelli, Micaela Sepe-Monti, Stefania Cannoni, Alessandra Pichi, Paolo Tisei, Anna Rosa Casini, Carla Buttinelli, Massimiliano Prencipe, Marco Salvetti, Giovanni Ristori
Dement Geriatr Cogn Disord (2003) 16 (1): 35–38.
Published Online: 08 May 2003
... in Alzheimer’s disease (AD), little is known about the role of antigen-specific immune responses. We investigated T cell reactivity to fragment 1–42 of amyloid-β (Aβ) and to N-terminal peptides of human mitochondrial and control microbial proteins. Thirty subjects with a diagnosis of probable AD according...